Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Behav Brain Res ; 469: 115065, 2024 Jul 09.
Artigo em Inglês | MEDLINE | ID: mdl-38782097

RESUMO

Acetaminophen (paracetamol) is one of the most popular analgesics for the management of fever and pain but few reports have investigated its antidepressant-like effect. Moreover, the role of the opioidergic pathway has been indicated in depression pathophysiology. This study aimed to examine the involvement of the opioid receptors in the antidepressant-like effect of acetaminophen after acute and sub-chronic administration using mice forced swimming test (FST). Our finding showed that administration of acetaminophen (50 and 100 mg/kg, i.p.) 30 min before the FST produced an antidepressant effect which was reduced by naloxone (1 mg/kg, i.p., a nonselective opioid receptor antagonist). Moreover, we observed that acetaminophen in higher doses (200 and 400 mg/kg) was ineffective. Also, the response of the non-effective dose of acetaminophen (25 mg/kg) was potentiated by the non-effective dose of morphine (0.1 mg/kg) in the FST that was antagonized by naloxone. Also, in contrast to morphine (10 mg/kg), acetaminophen (100 mg/kg, i.p.) induced neither tolerance to the anti-immobility behavior nor withdrawal syndrome after repeated administration. In addition, RT-PCR showed that hippocampal mu- and kappa-opioid receptor mRNA expression increased in mice after repeated administration of acetaminophen; however, morphine therapy for 6 days did not affect kappa-opioid receptor expression. Our findings demonstrated that acetaminophen in lower doses but not high doses revealed an antidepressant-like activity without inducing tolerance and withdrawal syndromes. Moreover, the observed effect of acetaminophen may be via altering the opioid system, particularly hippocampal mu- and kappa-receptors.


Assuntos
Acetaminofen , Antidepressivos , Relação Dose-Resposta a Droga , Naloxona , Antagonistas de Entorpecentes , Animais , Acetaminofen/farmacologia , Acetaminofen/administração & dosagem , Masculino , Camundongos , Antidepressivos/farmacologia , Antidepressivos/administração & dosagem , Naloxona/farmacologia , Antagonistas de Entorpecentes/farmacologia , Antagonistas de Entorpecentes/administração & dosagem , Natação , Depressão/tratamento farmacológico , Depressão/metabolismo , Morfina/farmacologia , Morfina/administração & dosagem , Hipocampo/efeitos dos fármacos , Hipocampo/metabolismo , Modelos Animais de Doenças , Analgésicos Opioides/farmacologia , Analgésicos Opioides/administração & dosagem , Analgésicos não Narcóticos/farmacologia , Analgésicos não Narcóticos/administração & dosagem , Receptores Opioides/metabolismo , Receptores Opioides/efeitos dos fármacos , Receptores Opioides mu/metabolismo , Receptores Opioides mu/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA